DMG-PEG2000

Research use only, not for human use.

DMG-PEG2000 is a lipid excipient that has been used in combination with other lipids in the formation of lipid nanoparticles.

DMG-PEG2000 is a lipid excipient that has been used in combination with other lipids in the formation of lipid nanoparticles. Formulations containing DMG-PEG2000 have been used in the development of lipid nanoparticles for the delivery of mRNA-based vaccines.

NP-3 (0.05-1.6 mg/mL; 24 hours) does not decrease the cytotoxicity of cells in 293T, HepG2, A549, and HeLa cell lines, but the DPPC and DMG-PEG coated nanoparticles reduce cell cytotoxicity. In addition, the transfection efficiency of DPPC/DMG-PEG/(lPEI/DNA) nanoparticles (NP-3) in 293 cells is improved, and the maximum transfection efficiency (~76% eGFP positive cells) is observed.

NP-3 (oral administration; 150 μg DNA per mouse; single dose) at 12, 24, and 36 h postadministration, luciferin substrate is intraperitoneally injected to verify its permeability. NP-3 group maintains high luciferase expression in the liver, lung, and intestine areas 12-24 h post-treatment.Additionally, NP-3 exhibits 1.5 times higher signal intensity than that of NP-1 or NP-2 group from 12 to 24 h postoral administration.

——

Others

Other Targets

Others

——

——

160743-62-4

570.9

C34H66O6

>98% (HPLC)

DMSO:100 mg/mL (Need ultrasonic)

——

——

(-20℃)

With Ice Pack

≥ 2 years